Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Market Cap

Capricor Therapeutics has a market cap or net worth of $222.96 million as of July 31, 2026. Its market cap has decreased by -40.37% in one year.

• Market Cap: 222.96M
• Enterprise Value: -40.86M
• 1-Year Change: -40.37%
• Ranking: #3808
• Category: Micro-Cap
• Stock Price: $3.85

Market Cap Chart

Chart

Since May 13, 2008, Capricor Therapeutics's market cap has increased from $130.10M to $222.96M, an increase of 71.38%. That is a compound annual growth rate of 3.00%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2026	223.00M	-83.10%
Dec 31, 2025	1.32B	110.26%
Dec 31, 2024	627.50M	316.67%
Dec 29, 2023	150.60M	54.62%
Dec 30, 2022	97.40M	37.57%
Dec 31, 2021	70.80M	1.00%
Dec 31, 2020	70.10M	1,198.15%
Dec 31, 2019	5.40M	-57.48%
Dec 31, 2018	12.70M	-68.72%
Dec 29, 2017	40.60M	-28.65%
Dec 30, 2016	56.90M	13.80%
Dec 31, 2015	50.00M	13.90%
Dec 31, 2014	43.90M	1,467.86%
Dec 31, 2013	2.80M	27.27%
Dec 31, 2012	2.20M	-89.91%
Dec 30, 2011	21.80M	1.40%
Dec 31, 2010	21.50M	-36.39%
Dec 31, 2009	33.80M	38.52%
Dec 31, 2008	24.40M	-81.25%
May 13, 2008	130.10M	-

View and export this data all the way back to 2008. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 31, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Aug 2, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
ProQR Therapeutics	251.20M
Anavex Life Sciences	250.21M
Fulcrum Therapeutics	247.88M
Adagene	246.45M
Turn Therapeutics	245.75M
Entrada Therapeutics	243.95M
Surrozen	241.84M
MacroGenics	240.27M